Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03687970 · ClinicalTrials.gov registry record · NA
A New Method for Identifying Sensory Changes in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN)
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT03687970 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 42 participants.
The verdict
NCT03687970, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The investigators propose that using the Diode Laser fiber type Selective Stimulator (DLss) in patients with chemotherapy-induced peripheral neuropathy (CIPN) will allow for the assessment of changes in small-fiber pain thresholds, to identify differences between subjects who received chemotherapy and developed painful CIPN, compared to subjects who received similar chemotherapy but did not develop painful CIPN (control group). Additionally, the investigators would like to investigate whether the response to DLss correlates with pain severity in patients with persistent painful neuropathy. The ultimate goal of this study is to develop a non-invasive, bedside quantitative test that is specific for painful CIPN. If the investigators' initial hypothesis is confirmed, the next step would be to design a prospective longitudinal study and assess changes in DLss early after initiation of chemotherapy, to determine whether this approach can help identify early predictive parameters of painful CIPN.
Interventions
- PROCEDURE Diode Laser fiber type Selective Stimulator
- OTHER Brief Pain Inventory
- OTHER Hospital Anxiety and Depression Scale
- OTHER Neuropathic Pain Symptom Inventory
- PROCEDURE Quantitative sensory testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2018-09-17 |
| Est. Completion | 2019-09-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03687970
The ClinicalTrials.gov registry entry for NCT03687970 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Diode Laser fiber type Selective Stimulator is the first listed.
NCT03687970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03687970 about?
NCT03687970 is a clinical study titled "A New Method for Identifying Sensory Changes in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN)". The investigators propose that using the Diode Laser fiber type Selective Stimulator (DLss) in patients with chemotherapy-induced peripheral neuropathy (CIPN) will allow for the assessment of changes in small-fiber pain thresholds, to identify differences between subjects who received chemotherapy a...
What is the current status of trial NCT03687970?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2018-09-17. Estimated completion is 2019-09-17.
What interventions are being tested in trial NCT03687970?
The interventions under investigation include: Diode Laser fiber type Selective Stimulator (PROCEDURE), Brief Pain Inventory (OTHER), Hospital Anxiety and Depression Scale (OTHER), Neuropathic Pain Symptom Inventory (OTHER), Quantitative sensory testing (PROCEDURE).
Who is sponsoring clinical trial NCT03687970?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.